The second largest group, constituting 20% of NBIA patients, is PLA2G6-associated neurodegeneration (PLAN) which is caused by mutations in phospholipase A2 (PLA2G6). This evidence concerns the gene PLA2G6 and neurodegeneration with brain iron accumulation.